Life Saving Drugs Program resources – Mucopolysaccharidosis type VI (MPS VI)
A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program.
This collection contains guidelines, forms and documents related to accessing galsulfase (Naglazyme®) under the Life Saving Drugs Program. Click to view the Naglazyme® product information on the Therapeutic Goods Administration website.
Medicines review documents
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.